European action for the diagnosis of early non-symptomatic type 1 diabetes for intervention
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 21 projects and 0 programmes
GRIP on MASH: global research initiative for patient screening on MASH
A biomarker-based platform for early diagnosis of chronic liver disease to enable personalized therapy
Synthetic data generation framework for integrated validation of use cases and AI healthcare applications
Biomarker enterprise to attack DKD
Cardiomyopathy in type 2 diabetes mellitus
EU patient-centric clinical trial platform
H2O Health outcomes observatory
Hypoglycaemia - REdefining SOLutions for better liVEs
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
Liver Investigation: Testing Marker Utility in Steatohepatitis
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
Stratification of obese phenotypes to optimize future obesity therapy
Diabetes research on patient stratification
European Bank for induced pluripotent Stem Cells
European Medical Information Framework
Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes
Stem cells for biological assays of novel drugs and predictive toxicology
Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
